Caplight Directory>Companies>KLISBio-preview>Klis


KLISBio

KLISBio

Private
MilanHealthcare & Life Scienceshttps://klis.bio/

Last Round

Grant

Feb 28, 2024

Total Funding Raised

$10.8M

Company Overview

KLISBio is a biotechnology company developing a new class of drugs for the treatment of chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

silk fibroinSILKBridgeperipheral nerve repairnerve guidebiomaterialsregenerative medicinetissue engineeringbiocompatible scaffoldssoft tissue repairrestorative surgerytissue regenerationimplantable medical devicesmedtechvascular graftbone graft substituterotator cuff repairdrug release system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KLISBio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KLISBio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 28, 2024
Series AApr 21, 2016
GrantDec 5, 2014
View all Funding Rounds

Key People

Founding team and executive leadership

Antonio Alessandrino

Founder CTO Board Member

Founding Team

Gabriele Grecchi

Chief Executive Officer Co-Founder

Founding Team

KLISBio Investors

Notable investors and investment history

InvestorRounds
European Innovation CouncilGrant
Principia SGRSeries A
View all Investors

KLISBio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KLISBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KLISBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan
Employee Range23
Year Founded2022
Last FundingFeb 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.